Edition:
United Kingdom

K2M Group Holdings Inc (KTWO.OQ)

KTWO.OQ on NASDAQ Stock Exchange Global Select Market

18.00USD
15 Dec 2017
Change (% chg)

$0.62 (+3.57%)
Prev Close
$17.38
Open
$17.47
Day's High
$18.00
Day's Low
$17.41
Volume
501,961
Avg. Vol
137,001
52-wk High
$25.96
52-wk Low
$16.44

Select another date:

Wed, Nov 1 2017

BRIEF-K2M Group Holdings reports Q3 loss per share $0.20

* K2M Group Holdings Inc reports third quarter 2017 financial results

BRIEF-K2M acquires FDA-cleared cervical static corpectomy cage

* K2M acquires world’s first & only FDA-cleared cervical static corpectomy cage

BRIEF-K2M Group Holdings enters into an amendment to senior secured credit facilities credit agreement

* K2M Group Holdings - ‍entered into an amendment to co's senior secured credit facilities credit agreement, dated as of October 29, 2012​ - Sec filing

BRIEF-K2M GROUP HOLDINGS SEES Q3 REVENUE ABOUT $62.7 MILLION

* K2M GROUP HOLDINGS, INC. REPORTS PRELIMINARY THIRD QUARTER REVENUE RESULTS AND UPDATES FULL YEAR 2017 REVENUE OUTLOOK

BRIEF-K2M Group Holdings President & Chief Executive Eric Major elected chairman of the board

* K2M Group Holdings, Inc. President & Chief Executive Officer Eric Major elected chairman of the board of directors

BRIEF-K2M receives FDA clearance for next-generation Yukon Oct spinal system

* K2M receives FDA clearance for next-generation Yukon Oct spinal system Source text for Eikon: Further company coverage:

BRIEF-K2m acquires license to comprehensive patent portfolio of expandable spinal implants to increase 3D-printed offerings

* K2M acquires exclusive license to comprehensive patent portfolio of expandable spinal implants to increase 3d-printed offerings Source text for Eikon: Further company coverage:

BRIEF-K2M Group Holdings Q2 loss per share $0.21

* K2M Group Holdings, Inc. reports second quarter 2017 financial results; reaffirms fiscal year 2017 outlook

BRIEF-K2M Group announces long-term exclusive distribution agreement with Mitsubishi subsidiary Japan Medicalnext Co

* K2m Group Holdings, Inc. Announces long-term exclusive distribution agreement with mitsubishi corporation subsidiary japan medicalnext co., ltd.

BRIEF-K2M receives FDA clearance & CE Mark for nile proximal fixation spinal system

* K2M receives FDA clearance & CE Mark for nile proximal fixation spinal system Source text for Eikon: Further company coverage:

Select another date: